Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TARS | AKRO | AGIO | ||
| Company | Tarsus Pharmaceuticals Inc | Akero Therapeutics Inc | Agios Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.52 | 28.09 | 35.50 | ||
| High | 53.62 | 29.77 | 36.30 | ||
| Low | 50.20 | 28.09 | 35.13 | ||
| Last | 52.91 | 29.34 | 35.42 | ||
| Change | +0.91 | +0.94 | -0.39 | ||
| % Change | +1.75% | +3.31% | -1.09% | ||
| Volume | 816,300 | 1,559,900 | 3,199,100 | ||
| 20-Day Average Volume | 540,540 | 609,990 | 1,125,945 | ||
| Previous Close | 52.00 | 28.40 | 35.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.19 | 30.54 | 49.91 | ||
| 20-Day Raw Stochastic | 64.23% | 33.45% | 1.06% | ||
| 20-Day Relative Strength | 62.87% | 47.02% | 33.00% | ||
| Weighted Alpha | +163.89 | +25.19 | +31.35 | ||
| Today's Opinion | 100% Buy | 40% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 24% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 12/13/24 | +1.56% since 12/13/24 | -9.10% since 12/13/24 | ||
| Low | 50.20 on 12/20/24 | 27.35 on 12/19/24 | 35.13 on 12/20/24 | ||
| High | 56.77 on 12/18/24 | 31.41 on 12/17/24 | 44.46 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +13.59% since 11/20/24 | -4.23% since 11/20/24 | -35.15% since 11/20/24 | ||
| Low | 45.19 on 11/21/24 | 27.35 on 12/19/24 | 35.13 on 12/20/24 | ||
| High | 56.77 on 12/18/24 | 33.30 on 11/25/24 | 62.45 on 12/06/24 | ||
| 3-Month | |||||
| %Chg | +53.32% since 09/20/24 | +4.49% since 09/20/24 | -23.91% since 09/20/24 | ||
| Low | 31.36 on 09/27/24 | 26.46 on 10/07/24 | 35.13 on 12/20/24 | ||
| High | 56.77 on 12/18/24 | 35.88 on 11/07/24 | 62.58 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +100.34% since 06/20/24 | +34.71% since 06/20/24 | -16.56% since 06/20/24 | ||
| Low | 20.08 on 08/05/24 | 21.02 on 07/05/24 | 35.13 on 12/20/24 | ||
| High | 56.77 on 12/18/24 | 35.88 on 11/07/24 | 62.58 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,022,591 | 2,047,903 | 2,020,002 | ||
| Shares Outstanding, K | 38,227 | 69,799 | 57,030 | ||
| Annual Sales | 17,450,000 | 0 | 26,820,000 | ||
| Annual Net Income | -135,890,000 | -151,760,000 | -352,090,000 | ||
| Last Quarter Sales | 48,120,000 | 0 | 8,960,000 | ||
| Last Quarter Net Income | -23,420,000 | -72,710,000 | 947,920,000 | ||
| 60-Month Beta | 1.04 | -0.23 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 11/13/24 | -1.05 on 11/08/24 | 4.20 on 10/31/24 | ||
| Latest Earnings Date | 11/13/24 | 11/11/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||